PROTACs: The Future of Leukemia Therapeutics.

Anwar, Zubair; Ali, Muhammad Shahzad; Galvano, Antonio; Perez, Alessandro; La Mantia, Maria; Bukhari, Ihtisham; Swiatczak, Bartlomiej

Anwar, Zubair; Ali, Muhammad Shahzad; Galvano, Antonio; Perez, Alessandro; La Mantia, Maria; Bukhari, Ihtisham; Swiatczak, Bartlomiej.

Afiliación

Anwar Z; Department of Surgical, Oncological, and Oral Sciences, Section of Medical Oncology, Uiniversity of Palermo, Palermo, Italy.
Ali MS; Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Turin, Italy.
Galvano A; Department of Surgical, Oncological, and Oral Sciences, Section of Medical Oncology, Uiniversity of Palermo, Palermo, Italy.
Perez A; Department of Surgical, Oncological, and Oral Sciences, Section of Medical Oncology, Uiniversity of Palermo, Palermo, Italy.
La Mantia M; Department of Surgical, Oncological, and Oral Sciences, Section of Medical Oncology, Uiniversity of Palermo, Palermo, Italy.
Bukhari I; The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Swiatczak B; Department of History of Science and Scientific Archeology, University of Science and Technology of China, Hefei, China.

Front Cell Dev Biol ; 10: 851087, 2022.

Article en En | MEDLINE | ID: mdl-36120561

Palabras clave

PROTACs; anticancer therapeutics; cancer; leukemia; linker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google